{Reference Type}: Journal Article
{Title}: Mechanisms of osteoporosis associated with chronic obstructive pulmonary disease.
{Author}: Inoue D;Inoue R;
{Journal}: J Bone Miner Metab
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 8
{Factor}: 2.976
{DOI}: 10.1007/s00774-024-01527-1
{Abstract}: Chronic obstructive pulmonary disease (COPD) is a disease characterized by chronic respiratory symptoms due to inflammatory and destructive changes of the lung leading to progressive airflow obstruction. Fragility fractures associated with osteoporosis are among major comorbidities and have significant impacts on quality of life and prognosis of patients with COPD. Evidence suggests that both decreased bone mineral density (BMD) and impaired bone quality contribute to bone fragility and resultant fractures in COPD. Although various clinical risk factors of osteoporosis have been described, mechanisms of COPD-associated osteoporosis are still largely unknown. In addition, its specific treatment has not been established, either. Previous studies have suggested involvement of low BMI and sarcopenia in the pathogenesis of COPD-associated osteoporosis. In this narrative review, we will propose critical roles of vitamin D deficiency and inflammation, both of which are often present in COPD and may underlie the development of osteosarcopenia and impaired bone quality, ultimately causing fractures in COPD patients.